Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metabolic Dysfunction-Associated Liver Disease”

291 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 291 results

Not applicableNot Yet RecruitingNCT06483711
What this trial is testing

Reducing Barriers to Lifestyle Modification for Newly Diagnosed MASLD

Who this might be right for
Metabolic Dysfunction-associated Steatotic Liver Disease
Stanford University 50
Large-scale testing (Phase 3)Looking for participantsNCT06528314
What this trial is testing

A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH

Who this might be right for
NASH - Nonalcoholic SteatohepatitisMASH - Metabolic Dysfunction-Associated Steatohepatitis
Akero Therapeutics, Inc 2,150
Large-scale testing (Phase 3)Looking for participantsNCT06632457
What this trial is testing

LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis

Who this might be right for
Metabolic Dysfunction Associated Steatohepatitis
Boehringer Ingelheim 1,590
Post-approval studies (Phase 4)Study completedNCT05493761
What this trial is testing

Effect of Anti-osteoporotic Medications on Nonalcoholic Fatty Liver Disease

Who this might be right for
Nonalcoholic Fatty LiverOsteoporosis, Postmenopausal
Aristotle University Of Thessaloniki 72
Not applicableNot Yet RecruitingNCT07630636
What this trial is testing

Temporal Eating Patterns and Metabolic Health

Who this might be right for
MASLD (Metabolic Dysfunction-Associated Steatotic Liver Disease)Early Motherhood
Maria Chondronikola 400
Not applicableNot Yet RecruitingNCT07777198
What this trial is testing

Liver Stiffness Changes by iLivTouch to Predict Liver-Related Events in MAFLD

Who this might be right for
MAFLD
Beijing Friendship Hospital 2,303
Not applicableStudy completedNCT07389122
What this trial is testing

Adherence and Tolerability of Four Very Low-Calorie Ketogenic Diet Approaches in Adults With Obesity or Complicated Overweight

Who this might be right for
Obesity & OverweightMASLD/MASH (Metabolic Dysfunction-Associated Steatotic Liver Disease / Metabolic Dysfunction-Associated Steatohepatitis)Type 2 Diabetes+1 more
University of Bologna 110
Not applicableNot Yet RecruitingNCT07386665
What this trial is testing

Impact of Circadian Exercise on Metabolic Dysfunction-Associated Steatotic Liver Disease in Postmenopausal Women

Who this might be right for
Metabolic Dysfunction-Associated Steatotic Liver DiseaseCardiometabolic DiseasesExercise
Universidad de Almeria 63
Not applicableLooking for participantsNCT07685353
What this trial is testing

Influence of Donor and Recipient Genetic Polymorphisms on Graft Steatosis After Liver Transplant

Who this might be right for
Chronic Liver Disease and Cirrhosis
Institute of Liver and Biliary Sciences, India 50
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07310407
What this trial is testing

Rutin and Vitamin C in Patients With Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD)

Who this might be right for
NAFLD
Ain Shams University 120
Not applicableEnrolling By InvitationNCT07456332
What this trial is testing

Effect on Body Weight Reduction of a Behavioral Intervention on Lifestyle Using a Digital Nutritional Program in People Living With HIV and Metabolic Dysfunction-associated Steatotic Liver Disease

Who this might be right for
Metabolic Dysfunction-Associated Steatotic Liver DiseasePeople Living With HIVLife Style
Hospital Universitari de Bellvitge 116
Testing effectiveness (Phase 2)Study completedNCT06482112
What this trial is testing

Alternate Dosing Study of MK-6024 in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) (MK-6024-016)

Who this might be right for
Metabolic Dysfunction-Associated Steatotic Liver DiseaseNon-alcoholic Fatty Liver DiseaseNonalcoholic Fatty Liver Disease+1 more
Merck Sharp & Dohme LLC 124
Large-scale testing (Phase 3)Looking for participantsNCT07165028
What this trial is testing

A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)

Who this might be right for
Metabolic Dysfunction-Associated Steatotic Liver Disease
Eli Lilly and Company 4,500
Post-approval studies (Phase 4)Not Yet RecruitingNCT07289750
What this trial is testing

The Effect of Alogliptin Combined With Actoplus Met on Glucose and Lipid Metabolism and Pancreatic Function in Patients With T2DM Complicated With MAFLD

Who this might be right for
T2DMMAFLD
The Fourth Affiliated Hospital of Zhejiang University School of Medicine 80
Post-approval studies (Phase 4)Looking for participantsNCT07718126
What this trial is testing

Pre-hepatectomy Rehabilitation in Obese MASLD-Complicated Living Liver Donors With Mazdutide (PRIME)

Who this might be right for
Metabolic Dysfunction-Associated SteatohepatitisHepatic SteatosisLiving Liver Donors
West China Hospital 60
Not applicableNot Yet RecruitingNCT07285135
What this trial is testing

Dietary Glycine Supplementation in Metabolic Dysfunction-associated Steatotic Liver Disease

Who this might be right for
Metabolic Dysfunction Associated Fatty Liver Disease
Singapore General Hospital 60
Not applicableNot Yet RecruitingNCT06682663
What this trial is testing

Impact of Live Streaming Exercise on Liver Health in MASLD Pregnant Women

Who this might be right for
Metabolic Dysfunction-associated Steatotic Liver Disease
Peking University 220
Early research (Phase 1)Not Yet RecruitingNCT07589400
What this trial is testing

Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Characteristics of ACT500 in Participants With Metabolic Dysfunction-Associated Steatotic Liver Disease Complicated With Chronic Hepatitis B

Who this might be right for
Metabolic Dysfunction-associated Steatotic Liver DiseaseChronic Hepatitis b
Xiamen Amoytop Biotech Co., Ltd. 24
Not applicableUnknownNCT06536933
What this trial is testing

Study of Metabolic Dysfunction-Associated Steatotic Liver Disease Among Sohag University Employees

Who this might be right for
Metabolic Dysfunction-Associated Steatotic Liver Disease
Sohag University 100
Not applicableEnrolling By InvitationNCT06986447
What this trial is testing

Assessment of Non-Invasive Testing in Major Liver-Related Outcomes

Who this might be right for
Metabolic Dysfunction-Associated Steatotic Liver DiseaseMASLDMASLD - Metabolic Dysfunction-Associated Steatotic Liver Disease+2 more
HRI-MAIL-NIT 1,689
Next Page